» Articles » PMID: 36077080

Molecular Changes in Relation to Alcohol Consumption and Hepatocellular Carcinoma

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Sep 9
PMID 36077080
Authors
Affiliations
Soon will be listed here.
Abstract

Alcohol is the one of the major causes of liver diseases and promotes liver cirrhosis and hepatocellular carcinoma (HCC). In hepatocytes, alcohol is converted to acetaldehyde, which causes hepatic steatosis, cellular apoptosis, endoplasmic reticulum stress, peroxidation, production of cytokines and reduces immune surveillance. Endotoxin and lipopolysaccharide produced from intestinal bacteria also enhance the production of cytokines. The development of hepatic fibrosis and the occurrence of HCC are induced by these alcohol metabolites. Several host genetic factors have recently been identified in this process. Here, we reviewed the molecular mechanism associated with HCC in alcoholic liver disease.

Citing Articles

Silencing of keratin 15 impairs viability and mobility while facilitating the doxorubicin chemosensitivity by inactivating the β‑catenin pathway in liver cancer.

Wang J, Zhu G Oncol Lett. 2023; 26(4):447.

PMID: 37720670 PMC: 10502946. DOI: 10.3892/ol.2023.14034.


Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy.

Kouroumalis E, Tsomidis I, Voumvouraki A Biomedicines. 2023; 11(4).

PMID: 37189787 PMC: 10135776. DOI: 10.3390/biomedicines11041166.


Molecular Mechanism of Chronic Viral and Non-Viral Liver Diseases.

Kanda T Int J Mol Sci. 2023; 24(7).

PMID: 37047190 PMC: 10094116. DOI: 10.3390/ijms24076218.


Mallotucin D, a Clerodane Diterpenoid from , Suppresses HepG2 Cell Growth via Inducing Autophagic Cell Death and Pyroptosis.

Dai X, Sun F, Deng K, Lin G, Yin W, Chen H Int J Mol Sci. 2022; 23(22).

PMID: 36430694 PMC: 9698996. DOI: 10.3390/ijms232214217.


Comparison of Surgical Resection and Percutaneous Ultrasonographic Guided Radiofrequency Ablation for Initial Recurrence of Hepatocellular Carcinoma in Early Stage following Curative Treatment.

Ohama H, Hiraoka A, Tada F, Kato K, Fukunishi Y, Yanagihara E Cancers (Basel). 2022; 14(22).

PMID: 36428616 PMC: 9688673. DOI: 10.3390/cancers14225524.

References
1.
Xu L, Hui A, Albanis E, Arthur M, OByrne S, Blaner W . Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut. 2004; 54(1):142-51. PMC: 1774377. DOI: 10.1136/gut.2004.042127. View

2.
Masuzaki R, Kanda T, Sasaki R, Matsumoto N, Ogawa M, Matsuoka S . Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives. Int J Mol Sci. 2020; 21(14). PMC: 7402287. DOI: 10.3390/ijms21144906. View

3.
Rajkovic I, Williams R . Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology. 1986; 6(2):252-62. DOI: 10.1002/hep.1840060217. View

4.
Ganne-Carrie N, Nahon P . Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol. 2019; 70(2):284-293. DOI: 10.1016/j.jhep.2018.10.008. View

5.
Afford S, Fisher N, Neil D, Fear J, Brun P, Hubscher S . Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol. 1999; 186(1):82-9. DOI: 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D. View